Giovanna Manzi

Pubblicazioni

Titolo Pubblicato in Anno
The Early Pharmacological Strategy with Inodilator, bEta-blockers, Mineralocorticoid Receptor Antagonists, Sodium-glucose coTransporter-2 Inhibitors and Angiotensin Receptor-neprylisin Inhibitors in Acute Heart Failure (PENTA-HF) CURRENT VASCULAR PHARMACOLOGY 2025
Echocardiography of the right heart in pulmonary arterial hypertension: insights from the ULTRA RIGHT VALUE study EUROPEAN HEART JOURNAL. IMAGING METHODS AND PRACTICE 2025
Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation MEDICINA 2025
Right heart reverse remodeling: “facta non verba” INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE 2025
TAPSE/sPAP and Inferior Vena Cava as a Risk Stratification Model in PAH: When the Pipe and Pump Are Not Enough ECHOCARDIOGRAPHY 2025
Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology CARDIOVASCULAR DRUGS AND THERAPY 2025
The right ventricle: the co-star in the complex history of heart failure EUROPEAN HEART JOURNAL SUPPLEMENTS 2025
Right ventricular/pulmonary artery coupling in patients with heart failure with preserved ejection fraction. a clue for pulmonary hypertension JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE 2024
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 2024
SGLT2i effect on atrial fibrillation: A network meta-analysis of randomized controlled trials JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY 2024
Prognostic assessment of hlm score in heart failure due to ischemic heart disease. a pilot study JOURNAL OF CLINICAL MEDICINE 2024
The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study HELIYON 2024
Biobanks: The unmet need in heart failure management VASCULAR PHARMACOLOGY 2023
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension CURRENT HEART FAILURE REPORTS 2023
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing JOURNAL OF CLINICAL MEDICINE 2023
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis INTERNATIONAL JOURNAL OF CARDIOLOGY 2023
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension JOURNAL OF CLINICAL MEDICINE 2022
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? EUROPEAN RESPIRATORY JOURNAL 2022
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension HEART FAILURE REVIEWS 2022
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma